Modern approach to hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Genetics

Background:

• Hepatocellular carcinoma (HCC) was historically considered a fatal liver disease.
• Advances in diagnostic and therapeutic tools have improved patient outcomes.
• Genetic research is revealing new insights into HCC development and progression.

Purpose of the Study:

• To review current advancements in HCC detection and treatment.
• To explore the application of microarray technology in understanding HCC genetics.
• To highlight the potential for targeted therapies based on genetic profiling.

Main Methods:

• Review of current diagnostic modalities, including ultrasonography for early lesion detection.
• Analysis of treatment effectiveness for resectable or ablated HCC lesions.
• Application of microarray technology to identify genetic variants and predictive gene signatures in HCC.

Main Results:

• Ultrasonography enables sensitive detection of small HCC lesions.
• Surgical resection and radiofrequency ablation are effective treatments for early HCC.
• Microarray analysis has identified distinct genetic subtypes of HCC and gene signatures associated with poor prognosis and metastasis.

Conclusions:

• Hepatocellular carcinoma is theoretically curable in most patients with timely application of current diagnostic and treatment tools.
• Genetic profiling of HCC is crucial for predicting outcomes and identifying novel therapeutic targets.
• Future research holds promise for developing more effective, targeted therapies for liver cancer.